TGen News & Press Releases : TGen, ASU, NAU, UArizona and ADHS compile 100,000 sequenced genomes of COVID
Main Image

TGen, ASU, NAU, UArizona and ADHS compile 100,000 sequenced genomes of COVID

Arizona COVID-19 Genomics Union positions state to play a role in CDC’s national pathogen genomics strategy

FLAGSTAFF, Ariz. — May 3, 2022 — A massive effort to track the COVID-19 pandemic in Arizona over the past two years resulted in the genomic sequencing of more than 100,000 samples of the COVID-19 virus by a coalition of TGen, Northern Arizona University (NAU), Arizona State University (ASU), the University of Arizona (UArizona), and the Arizona Department of Health Services (ADHS). This joint enterprise provides a proof-of-concept for building a 21st-century infectious-disease surveillance system to help prevent, detect, monitor and overcome the next pandemic.

As a result of this collaboration, Arizona is playing a major role in a growing nationwide and worldwide effort to use genomics to track infectious diseases, such as COVID-19. As such, Arizona researchers will be competing to be part of the Pathogen Genomics Centers of Excellence, a national network funded by the U.S. Centers for Disease Control and Prevention (CDC) that would expand and deepen infectious disease collaborations between U.S. public health agencies and universities.

“It is only by sequencing samples of the COVID virus — using the power of genomic technologies — that scientists here in Arizona, and our colleagues around the world, have kept track of all the mutations and subsequent COVID variants during this pandemic,” said David Engelthaler, Ph.D., Director of TGen’s Pathogen and Microbiome Division, the institute’s infectious disease branch in Flagstaff. The pandemic’s weekly progression was documented on the Arizona COVID Sequencing Dashboard compiled by TGen (the Translational Genomics Research Institute), part of City of Hope.

“When it comes to genomics, compiling 100,000 sequences is huge,” said Dr. Engelthaler, who supervised the collection and curation of Arizona’s COVID genomes. “Never before has a feat like this been accomplished for an infectious pathogen, but it’s really only the beginning of how we can use next-generation science and technology, in real time, to make a real difference.”

Arizona sequencing tracks the pandemic

Genomic sequencing is the spelling out of the DNA code — or in the case of a virus, the RNA code — that makes up an individual organism. Human DNA is about 3 billion letters long, while the RNA of COVID is about 20,000 letters long. The letters of code can change, or mutate, each time the organism replicates, which in the case of COVID resulted in thousands of mutations and dozens of significant variants that changed the transmissibility and virulence of this pandemic.

“The 100,000 milestone represents a lot of hard work and coordination across all three state universities, TGen and ADHS,” said Paul Keim, Ph.D., a TGen Distinguished Professor, the Executive Director of the NAU’s Pathogen and Microbiome Institute and one of the world’s leading authorities on infectious diseases.

“Arizona was not left behind in tracking the variants of SARS-CoV-2, the virus that causes COVID. As the global scientific community was identifying and tracking variants, Arizona was engaged and knew where we stood at all times,” said Dr. Keim. “With our surveillance data, we could learn from global efforts, make predictions for Arizona, and respond to mitigate the pandemic as it arrived here.”

ACGU provides critical data about Arizona

At the start of the pandemic in early 2020, TGen and Arizona’s three publicly funded universities came together to form the Arizona COVID-19 Genomics Union (ACGU, which is also the four chemical letters of RNA). Its expressed purpose is harnessing the power of state-of-the-art biotechnology and “big data” analysis to better understand how COVID evolves, how it is transmitted and how and where it moves through the general population.

The ACGU is one of many scientific groups across the globe working to track COVID through the rapid sharing of data and analysis, which has proved critical to the worldwide scientific, medical and public health understanding of the pandemic.

“The AGCU has really exceeded my expectations from when we founded it,” said Michael Worobey, head of UArizona’s Department of Ecology and Evolutionary Biology, who is world-renowned for his work on viral pandemics.

“We are among a small and elite group of U.S. states that have generated a full coronavirus genome sequence for about 1 percent of the total population,” Dr. Worobey said. “The future of preventing and controlling pandemics will hinge on the power of ‘genomic epidemiology.’ Our system, our teamwork — the depth of our bench — means that we will continue to lead the way in these important efforts.”

Arizona scientists accelerate technology

“Sequencing allows us to stay ahead of the SARS-CoV-2 virus as it evolves new variants, from the Alpha variant to Omicron and beyond,” said Efrem Lim, Ph.D., Assistant Professor in ASU’s Biodesign Center for Fundamental and Applied Microbiomics.

“This real-time surveillance makes a difference for public health responses. As scientists, we have a responsibility to care for our communities,” said Dr. Lim, who helped accelerate rapid COVID sequencing and oversaw a team at ASU that has now sequenced more than 40,000 of those genomes. “The statewide ACGU team has worked together since the start of the pandemic. This has meant that Arizona has not been left in the dark. Arizona can count on us no matter what the future holds — in this pandemic, or the next.”

The Arizona COVID Sequencing Dashboard was developed and maintained by TGen for Arizona, ADHS and the CDC. Since its launch in February 2021, it has recorded more than 103,000 genomic sequences from Arizona COVID patients. The site has recorded more than 217,000 visits.

“We have shown that we can apply these cutting edge tools in a time of emergency and provide intelligence to health officials quickly, and cost effectively,” said Dr. Engelthaler. “Now is the time to parlay these successes into a more complete pathogen intelligence gathering system, and thankfully, Arizona has the innovation and collaborative spirit to do just that.”

# # #

About TGen, part of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is part of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: CityofHope.org.  This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: tgen.org. Follow TGen on FacebookLinkedIn and Twitter @TGen.

About Northern Arizona University
Northern Arizona University is a high-research institution providing exceptional educational opportunities in Arizona and beyond. NAU delivers a student-centered experience to its nearly 30,000 students in Flagstaff, statewide and online through rigorous academic programs in a supportive, inclusive and diverse environment. Dedicated, world-renowned faculty help ensure students achieve academic excellence, experience personal growth, have meaningful research opportunities and are positioned for personal and professional success. 

Media Contact:
Galen Perry
Marketing and Communication
602-343-8423
[email protected]

 


Media Contact



RSS Feed

Newsletter